Literature DB >> 9874191

High dose chemotherapy for childhood ependymona.

J Grill, C Kalifa.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9874191     DOI: 10.1023/a:1017109414966

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  2 in total

1.  Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

Authors:  S Dupuis-Girod; O Hartmann; E Benhamou; F Doz; F Mechinaud; E Bouffet; C Coze; C Kalifa
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.

Authors:  J Grill; C Kalifa; F Doz; C Schoepfer; C Sainte-Rose; D Couanet; M J Terrier-Lacombe; D Valteau-Couanet; O Hartmann
Journal:  Pediatr Neurosurg       Date:  1996-07       Impact factor: 1.162

  2 in total
  4 in total

1.  Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.

Authors:  A Korshunov; R Sycheva; V Timirgaz; A Golanov
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 2.  Chemotherapy for intramedullary spinal cord tumors.

Authors:  C Balmaceda
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

Review 3.  EANO guidelines for the diagnosis and treatment of ependymal tumors.

Authors:  Roberta Rudà; Guido Reifenberger; Didier Frappaz; Stefan M Pfister; Anne Laprie; Thomas Santarius; Patrick Roth; Joerg Christian Tonn; Riccardo Soffietti; Michael Weller; Elizabeth Cohen-Jonathan Moyal
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

Review 4.  Ependymoma: Evaluation and Management Updates.

Authors:  Roberta Rudà; Francesco Bruno; Alessia Pellerino; Riccardo Soffietti
Journal:  Curr Oncol Rep       Date:  2022-04-06       Impact factor: 5.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.